You have 9 free searches left this month | for more free features.

Human epidermal growth factor receptor 2 Positive Breast Cancer

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Using Diffuse Optical Spectroscopic Imaging

Withdrawn
  • Breast Cancer
  • Diffuse Optical Spectroscopy Imaging
  • Irvine, California
    Beckman Laser Institute
Oct 28, 2022

Hematological Malignancy, Cancer-Related Anemia Trial in Wuhan (Shengxuening Tablet, Ferrous succinate)

Recruiting
  • Hematological Malignancy
  • Cancer-Related Anemia
  • Shengxuening Tablet
  • Ferrous succinate
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Mar 13, 2023

Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • Prostate Adenocarcinoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 23, 2022

Eswatini After Transition To Dolutegravir-Based Treatment

Recruiting
  • Neural Tube Defects
  • +2 more
    • Lubombo, Swaziland
    • +4 more
    May 22, 2023

    Multiple Myeloma Trial (Dara-VRd intensification, Dara-R maintenance, AHCT intensification, Dara-R maintenance, AHCT

    Not yet recruiting
    • Multiple Myeloma
    • Dara-VRd intensification, Dara-R maintenance
    • +4 more
    • (no location specified)
    Dec 13, 2022

    Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)

    Recruiting
    • Gastric Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 27, 2023

    Cognition in Older Breast Cancer Survivors: Treatment Exposure,

    Active, not recruiting
    • Breast Cancer Survivors
      • Duarte, California
      • +1 more
      May 20, 2022

      Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +

      Recruiting
      • Gastric Cancer
      • +9 more
      • Tumor Infiltrating Lymphocytes (TIL)
      • Fludarabine + Cyclophosphamide combination
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jul 21, 2022

      Breast Tumor, Inflammatory Breast Carcinoma Trial in Houston (Photoacoustic Imaging)

      Terminated
      • Breast Neoplasm
      • Inflammatory Breast Carcinoma
      • Photoacoustic Imaging
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 24, 2021

      Renal Cell Carcinoma Metastatic Trial in France (KidneyPRO, standard follow-up)

      Recruiting
      • Renal Cell Carcinoma Metastatic
      • KidneyPRO
      • standard follow-up
      • Angers, France
      • +12 more
      May 2, 2022

      Apnea During Procedural Sedation Trial (Noninvasive Ventilator (V60, Philips))

      Completed
      • Apnea During Procedural Sedation
      • Noninvasive Ventilator (V60, Philips)
      • (no location specified)
      Apr 26, 2021

      Adolescent Behavior, Adolescent Problem Behavior, Risk Reduction Trial (Tennessee Youth Prepared for Success)

      Not yet recruiting
      • Adolescent Behavior
      • +2 more
      • Tennessee Youth Prepared for Success
      • (no location specified)
      Aug 17, 2023

      Breast Tumors, Tumor Metastasis Trial in Boston, Canton (CodaLytic)

      Not yet recruiting
      • Breast Neoplasms
      • Neoplasm Metastasis
      • CodaLytic
      • Boston, Massachusetts
      • +1 more
      Oct 28, 2022

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Recurrent Malignant Solid Tumor Trial in Houston (Laboratory

      Completed
      • Advanced Malignant Solid Neoplasm
      • +3 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 21, 2022

      Low Back Pain Trial in Madinat al Fayyum (intra-articular Platelet rich fibrin and lidocaine, methylprednisolone acetate and

      Recruiting
      • Low Back Pain
      • intra-articular Platelet rich fibrin and lidocaine
      • methylprednisolone acetate and lidocaine
      • Madīnat al Fayyūm, Faiyum Governorate, Egypt
        Fayoum University hospital
      Jul 25, 2022

      COVID-19 Trial in Changde, Changning, Zhuzhou (Omicron COVID-19 Vaccine (Vero Cell), Inactivated, COVID-19 Vaccine (Vero Cell),

      Recruiting
      • COVID-19
      • Omicron COVID-19 Vaccine (Vero Cell), Inactivated
      • COVID-19 Vaccine (Vero Cell), Inactivated
      • Changde, Hunan, China
      • +2 more
      May 30, 2022

      Hypertension Trial in Guangzhou (Nicotinamide mononucleotide supplied as 400mg capsule, Lifestyle modification)

      Recruiting
      • Hypertension
      • Nicotinamide mononucleotide supplied as 400mg capsule
      • Lifestyle modification
      • Guangzhou, Guangdong, China
        First Affiliated Hospital,Sun Yat-sen University
      Jan 17, 2022

      Concentration of BRIUMVI™ (Ublituximab) in Breast Milk

      Not yet recruiting
      • Relapsing Multiple Sclerosis
      • No intervention
      • (no location specified)
      Nov 16, 2023

      Bioequivalence Trial in Chennai (Levodopa 250mg and Carbidopa 25mg Test Drug tablet, Levodopa 250mg and Carbidopa 25mg Referent

      Completed
      • Bioequivalence
      • Levodopa 250mg and Carbidopa 25mg Test Drug tablet
      • Levodopa 250mg and Carbidopa 25mg Referent Product tablet
      • Chennai, Tamil Nadu, India
        Azidus Laboratories Ltd.
      Mar 7, 2022

      Skin Condition Trial in Cheras, Petaling Jaya (Rice ceramide supplementation)

      Completed
      • Skin Condition
      • Rice ceramide supplementation
      • Cheras, Kuala Lumpur, Malaysia
      • +1 more
      Sep 27, 2022

      Refractory Malignant Solid Tumor Trial (PCNA Inhibitor AOH1996)

      Recruiting
      • Refractory Malignant Solid Neoplasm
      • PCNA Inhibitor AOH1996
      • Scottsdale, Arizona
      • +1 more
      Sep 29, 2022

      Metastatic Castration-resistant Prostate Cancer (mCRPC), Metastatic Urothelial Carcinoma, Metastatic Renal Cell Carcinoma Trial

      Completed
      • Metastatic Castration-resistant Prostate Cancer (mCRPC)
      • +2 more
      • Isovue-M 200
      • Durham, North Carolina
        Duke University Medical Center
      Apr 1, 2022

      Hepatocellular Carcinoma Trial in Yerevan

      Recruiting
      • Hepatocellular Carcinoma
        • Yerevan, Armenia
          Nikomed Medical Center
        Jun 28, 2023

        Rectal Cancer Stage III, Rectal Cancer Stage IV Trial in Beijing (procedure, drug, device, diagnostic test)

        Not yet recruiting
        • Rectal Cancer Stage III
        • Rectal Cancer Stage IV
        • Sentinel lymph node biopsy
        • +5 more
        • Beijing, Beijing, China
          National Cancer Center
        Apr 26, 2023